{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:26:57Z","timestamp":1792290417344,"version":"4.4.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clim.2024.109930","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T11:46:14Z","timestamp":1707479174000},"page":"109930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery"],"prefix":"10.1016","volume":"261","author":[{"given":"Ilayda","family":"Baydemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.","family":"Dulfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Dom\u00ednguez-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.109930_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.281.1.61","article-title":"Trends in infectious disease mortality in the United States during the 20th century","volume":"281","author":"Armstrong","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2024.109930_bb0010","first-page":"122","article-title":"Impact of vaccines universally recommended for children\u2013United States, 1990\u20131999","volume":"25","year":"1999","journal-title":"Can. Commun. Dis. Rep."},{"key":"10.1016\/j.clim.2024.109930_bb0015","first-page":"8","article-title":"Demografie van Nederland 1997","volume":"46","author":"Prins","year":"1998","journal-title":"Maandstat. Bevolk."},{"key":"10.1016\/j.clim.2024.109930_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(23)00860-7","article-title":"The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990\u20132019: a systematic analysis of the Global Burden of Disease Study 2019","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2024.109930_bb0025","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.109930_bb0030","author":"World Health Organization"},{"key":"10.1016\/j.clim.2024.109930_bb0035","author":"World Health Organization"},{"key":"10.1016\/j.clim.2024.109930_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03324904","article-title":"Immunosenescence and vaccine failure in the elderly","volume":"21","author":"Grubeck-Loebenstein","year":"2009","journal-title":"Aging Clin. Exp. Res."},{"issue":"8","key":"10.1016\/j.clim.2024.109930_bb0045","first-page":"1","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"81","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"20","key":"10.1016\/j.clim.2024.109930_bb0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"206","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2024.109930_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.clim.2024.109930_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: A memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clim.2024.109930_bb0065","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.clim.2024.109930_bb0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.clim.2024.109930_bb0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children","volume":"204","author":"Aaby","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0080","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","article-title":"BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa: A non-specific beneficial effect of BCG?","volume":"21","author":"Garly","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2024.109930_bb0085","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and neonatal mortality among infants weighing","volume":"65","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0090","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiu508","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial","volume":"211","author":"Jensen","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/jpids\/piy029","article-title":"BCG vaccination at birth and rate of hospitalization for infection until 15 months of age in Danish children: A randomized clinical multicenter trial","volume":"8","author":"Stensballe","year":"2019","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"10.1016\/j.clim.2024.109930_bb0100","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/cid\/civ452","article-title":"Development of BCG scar and subsequent morbidity and mortality in rural Guinea-Bissau","volume":"61","author":"Storgaard","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-015-1497-8","article-title":"Child survival and BCG vaccination: a community based prospective cohort study in Uganda","volume":"15","author":"Nankabirwa","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clim.2024.109930_bb0110","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ije\/dyh392","article-title":"BCG vaccination scar associated with better childhood survival in Guinea-Bissau","volume":"34","author":"Roth","year":"2005","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.clim.2024.109930_bb0115","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.clim.2024.109930_bb0120","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana Datau","year":"2011","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.clim.2024.109930_bb0125","doi-asserted-by":"crossref","DOI":"10.3143\/geriatrics.42.34","article-title":"Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations","author":"Ohrui","year":"2005","journal-title":"Jpn. J. Geriatr."},{"key":"10.1016\/j.clim.2024.109930_bb0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of infection with Mycobacteriumtuberculosis by H4:IC31\u00ae vaccination or BCG revaccination in adolescents","volume":"379","author":"Nemes","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.109930_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clim.2024.109930_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08659-3","article-title":"Outcomes of controlled human malaria infection after BCG vaccination","author":"Walk","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2024.109930_bb0145","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: A beneficial effect of BCG vaccination for girls: community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.clim.2024.109930_bb0150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41577-020-0338-x","article-title":"The non-specific and sex-differential effects of vaccines","volume":"208","author":"Aaby","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jpids\/piy142","article-title":"Journal of the pediatric infectious diseases society maternal priming: Bacillus Calmette-Gu\u00e9rin (BCG) vaccine scarring in mothers enhances the survival of their child with a BCG vaccine scar","volume":"9","author":"Berendsen","year":"2020","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"10.1016\/j.clim.2024.109930_bb0160","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/bmj.c6495","article-title":"Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial","volume":"341","author":"Aaby","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.clim.2024.109930_bb0165","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cid\/ciu354","article-title":"Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival","volume":"59","author":"Aaby","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0170","article-title":"Measles, mumps, and rubella vaccine at age 6 months and hospitalisation for infection before age 12 months: randomised controlled trial","volume":"381","author":"Zimakoff","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.clim.2024.109930_bb0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vaccine.2016.11.049","article-title":"A general measles vaccination campaign in urban Guinea-Bissau: comparing child mortality among participants and non-participants","volume":"35","author":"Byberg","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2024.109930_bb0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/ciy433","article-title":"Revaccination with measles-mumps-rubella vaccine and infectious disease morbidity: A Danish register-based cohort study","volume":"68","author":"S\u00f8rup","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0185","article-title":"Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands","volume":"358","author":"Tielemans","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.clim.2024.109930_bb0190","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.38261.496366.82","article-title":"Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso","volume":"329","author":"Vaugelade","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.clim.2024.109930_bb0195","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ije\/dyh005","article-title":"The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study","volume":"33","author":"Aaby","year":"2004","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.clim.2024.109930_bb0200","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/ije\/20.2.474","article-title":"Childhood mortality among users and non-users of primary health care in a rural west African community","volume":"20","author":"Velema","year":"1991","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.clim.2024.109930_bb0205","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1365-3156.2005.01434.x","article-title":"Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population","volume":"10","author":"Moulton","year":"2005","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.clim.2024.109930_bb0210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ije\/dyh262","article-title":"Benefits of routine immunizations on childhood survival in Tari, southern Highlands Province, Papua New Guinea","volume":"34","author":"Lehmann","year":"2005","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.clim.2024.109930_bb0215","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/archdischild-2011-300646","article-title":"Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial","volume":"97","author":"Aaby","year":"2012","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.clim.2024.109930_bb0220","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.inf.0000227829.64686.ae","article-title":"Sex differential effects of routine immunizations and childhood survival in rural Malawi","volume":"25","author":"Aaby","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.clim.2024.109930_bb0225","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(03)13771-3","article-title":"Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies","volume":"361","author":"Aaby","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.clim.2024.109930_bb0230","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.vaccine.2011.01.071","article-title":"Sex differences in the vaccine-specific and non-targeted effects of vaccines","volume":"29","author":"Flanagan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2024.109930_bb0235","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Gu\u00e9rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.109930_bb0240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clim.2024.109930_bb0245","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1172\/JCI133935","article-title":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner","volume":"130","author":"Koeken","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.109930_bb0250","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.vaccine.2015.02.056","article-title":"Variation of growth in the production of the BCG vaccine and the association with the immune response. An observational study within a randomised trial","volume":"33","author":"Biering-S\u00f8rensen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2024.109930_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109208","article-title":"The impact of BCG dose and revaccination on trained immunity","volume":"246","author":"Debisarun","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.immuni.2023.12.005","article-title":"Multi-omics analysis of innate and adaptive responses to BCG vaccination reveals epigenetic cell states that predict trained immunity","volume":"57","author":"Moorlag","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.109930_bb0265","article-title":"Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge","volume":"219","author":"Hilligan","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.109930_bb0270","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.109930_bb0275","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vaccine.2019.10.034","article-title":"Stopping live vaccines after disease eradication may increase mortality","volume":"38","author":"Aaby","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2024.109930_bb0280","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac340","article-title":"Stopping oral polio vaccine (OPV) after defeating poliomyelitis in low- and middle-income countries: harmful unintended consequences? Review of the nonspecific effects of OPV","volume":"9","author":"Aaby","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101049","article-title":"Parental Bacillus Calmette-Gu\u00e9rin vaccine scars decrease infant mortality in the first six weeks of life: A retrospective cohort study","volume":"39","author":"Berendsen","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.clim.2024.109930_bb0290","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/resp.13885","article-title":"National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19","volume":"25","author":"Ebina-Shibuya","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.clim.2024.109930_bb0295","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.109930_bb0300","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cegh.2020.08.015","article-title":"Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries","volume":"9","author":"Joy","year":"2021","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"10.1016\/j.clim.2024.109930_bb0305","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1080\/21645515.2021.1872344","article-title":"Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany","volume":"17","author":"Mar\u00edn-Hern\u00e1ndez","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.clim.2024.109930_bb0310","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2024.109930_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100728","article-title":"Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes","volume":"3","author":"Faustman","year":"2022","journal-title":"Cell Reports Med."},{"key":"10.1016\/j.clim.2024.109930_bb0320","article-title":"ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk","volume":"13","author":"Tsilika","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0325","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s40121-022-00703-y","article-title":"Efficacy of Bacillus Calmette-Gu\u00e9rin (BCG) vaccination in reducing the incidence and severity of COVID-19 in high-risk population (BRIC): a phase III, multi-Centre, quadruple-blind randomised control trial","volume":"11","author":"Sinha","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.clim.2024.109930_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841868","article-title":"Efficacy and safety of BCG revaccination with M. Bovis BCG Moscow to prevent COVID-19 infection in health care workers: A randomized phase II clinical trial","volume":"13","author":"dos Anjos","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0335","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMoa2212616","article-title":"Randomized trial of BCG vaccine to protect against Covid-19 in health care workers","volume":"388","author":"Pittet","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.109930_bb0340","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00356-23","article-title":"BCG vaccination of health care workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomized placebo-controlled trial","volume":"14","author":"Claus","year":"2023","journal-title":"MBio"},{"key":"10.1016\/j.clim.2024.109930_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10020314","volume":"10","author":"Czajka","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.clim.2024.109930_bb0350","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.cmi.2022.04.009","article-title":"Bacillus Calmette-Gu\u00e9rin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial","volume":"28","author":"ten Doesschate","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.clim.2024.109930_bb0355","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.cmi.2023.01.019","article-title":"Bacillus Calmette-Gu\u00e9rin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial","volume":"29","author":"Koekenbier","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.clim.2024.109930_bb0360","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2023.02.014","article-title":"The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-the results of ProBCG: a multicenter randomized clinical trial in Brazil","volume":"130","author":"Santos","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0365","doi-asserted-by":"crossref","first-page":"E938","DOI":"10.1093\/cid\/ciac182","article-title":"Efficacy of BCG vaccination against respiratory tract infections in older adults during the coronavirus disease 2019 pandemic","volume":"75","author":"Moorlag","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0370","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101718118","article-title":"Old vaccines for new infections: exploiting innate immunity to control COVID-19 and prevent future pandemics","volume":"118","author":"Chumakov","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.109930_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106733","article-title":"Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?","volume":"26","author":"Benn","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.clim.2024.109930_bb0380","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162581","article-title":"Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine","volume":"133","author":"Murphy","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.109930_bb0385","doi-asserted-by":"crossref","first-page":"1242380","DOI":"10.3389\/fimmu.2023.1242380","article-title":"BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and toll-like receptor agonists","volume":"14","author":"No\u00e9","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1252554","article-title":"Trained immunity: a cutting edge approach for designing novel vaccines against parasitic diseases?","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105088","article-title":"The role of IL-32 in Bacillus Calmette-Gu\u00e9rin (BCG)-induced trained immunity in infections caused by different Leishmania spp","volume":"158","author":"Silva","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.clim.2024.109930_bb0400","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2024.109930_bb0405","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/eji.202149577","article-title":"An integrative genomics approach identifies KDM4 as a modulator of trained immunity","volume":"52","author":"Moorlag","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107548","article-title":"The Set7 lysine methyltransferase regulates plasticity in oxidative phosphorylation necessary for trained immunity induced by \u03b2-glucan","volume":"31","author":"Keating","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2024.109930_bb0415","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/ni.3771","article-title":"Gene regulation in the immune system by long noncoding RNAs","volume":"18","author":"Chen","year":"2017","journal-title":"Nat. Immunol."},{"issue":"51","key":"10.1016\/j.clim.2024.109930_bb0420","first-page":"138","article-title":"Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments","volume":"511","author":"Fanucchi","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2024.109930_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12110-2","article-title":"Anti-mycobacterial activity correlates with altered DNA methylation pattern in immune cells from BCG-vaccinated subjects","volume":"7","author":"Verma","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2024.109930_bb0430","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of myelopoiesis progenitors is an integral component of trained immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.109930_bb0435","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3389\/fimmu.2018.03155","article-title":"MTOR-dependent oxidative stress regulates oxLDL-induced trained innate immunity in human monocytes","volume":"10","author":"Sohrabi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0440","doi-asserted-by":"crossref","DOI":"10.1126\/science.1250684","article-title":"MTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity","author":"Cheng","year":"2014","journal-title":"Science (80-.)"},{"key":"10.1016\/j.clim.2024.109930_bb0445","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.smim.2016.09.002","article-title":"Immunometabolic circuits in trained immunity","volume":"28","author":"Arts","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0450","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","article-title":"Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity","volume":"24","author":"Arts","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.clim.2024.109930_bb0455","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.it.2019.05.007","article-title":"The immunomodulatory potential of the metabolite itaconate","volume":"40","author":"Hooftman","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0460","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2018.09.003","article-title":"The Itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity","volume":"29","author":"Dom\u00ednguez-Andr\u00e9s","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.clim.2024.109930_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112658","article-title":"Dimethyl itaconate induces long-term innate immune responses and confers protection against infection","volume":"42","author":"Ferreira","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2024.109930_bb0470","doi-asserted-by":"crossref","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science (80-.)"},{"key":"10.1016\/j.clim.2024.109930_bb0475","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00109-020-01915-w","article-title":"Rewiring of glucose metabolism defines trained immunity induced by oxidized low-density lipoprotein","volume":"98","author":"Keating","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.clim.2024.109930_bb0480","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.clim.2024.109930_bb0485","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.clim.2024.109930_bb0490","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.clim.2024.109930_bb0495","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbadis.2017.12.029","article-title":"SIRT1 regulates inflammation response of macrophages in sepsis mediated by long noncoding RNA","volume":"1864","author":"Jia","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0500","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cell.2009.12.041","article-title":"The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha","volume":"140","author":"Zhong","year":"2010","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.clim.2024.109930_bb0505","first-page":"1","article-title":"Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males","volume":"91","author":"Cleophas","year":"2019","journal-title":"Sci. Report."},{"key":"10.1016\/j.clim.2024.109930_bb0510","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/annrheumdis-2014-206258","article-title":"Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases","volume":"75","author":"Cleophas","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0515","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","author":"Aaby","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0520","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cid\/cix340","article-title":"Beneficial nonspecific effects of Oral polio vaccine (OPV): implications for the cessation of OPV?","volume":"65","author":"Aaby","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0525","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1473-3099(20)30653-8","article-title":"BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial","volume":"21","author":"Prentice","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.clim.2024.109930_bb0530","article-title":"Mycobacterium bovis BCG given at birth followed by inactivated respiratory syncytial virus vaccine prevents vaccine-enhanced disease by promoting trained macrophages and resident memory T cells","volume":"97","author":"Wang","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2024.109930_bb0535","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217084","article-title":"Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung","volume":"15","author":"Kang","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.clim.2024.109930_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103314","article-title":"The use of directed evolution to create a stable and immunogenic recombinant BCG expressing a modified HIV-1 gag antigen","volume":"9","author":"Chapman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.109930_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00643","article-title":"Development of a live recombinant BCG expressing human immunodeficiency virus type 1 (HIV-1) gag using a pMyong2 vector system: potential use as a novel HIV-1 vaccine","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0550","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/vaccines7030078","article-title":"Recombinant BCG expressing HTI prime and recombinant ChAdOx1 boost is safe and elicits HIV-1-specific T-cell responses in BALB\/c mice","volume":"7","author":"Kilpel\u00e4inen","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.clim.2024.109930_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104187","article-title":"New disease old vaccine: is recombinant BCG vaccine an answer for COVID-19?","volume":"356","author":"Gupta","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107733","article-title":"Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells","volume":"26","author":"Singh","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.clim.2024.109930_bb0565","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157393","article-title":"Bacillus Calmette-Gu\u00e9rin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice","volume":"7","author":"Zhang","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.clim.2024.109930_bb0570","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/cei.13469","article-title":"Recombinant mycobacterium bovis BCG is a promising platform to develop vaccines against trypansoma cruzi infection","volume":"201","author":"Bontempi","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0575","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.celrep.2019.08.004","article-title":"\u03b2-Glucan-induced trained immunity protects against Leishmania braziliensis infection: a crucial role for IL-32","volume":"28","author":"dos Santos","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2024.109930_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10020234","article-title":"Recombinant BCG expressing the subunit 1 of pertussis toxin induces innate immune memory and confers protection against non-related pathogens","volume":"10","author":"Kanno","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.clim.2024.109930_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100185","article-title":"Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination","volume":"2","author":"Vierboom","year":"2021","journal-title":"Cell Reports Med."},{"key":"10.1016\/j.clim.2024.109930_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041168","article-title":"Long-term benefit of perlingual polybacterial vaccines in patients with systemic autoimmune diseases and active immunosuppression","volume":"11","author":"P\u00e9rez-Sancrist\u00f3bal","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.clim.2024.109930_bb0595","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1164\/rccm.202003-0520OC","article-title":"Bacterial mucosal immunotherapy with MV130 prevents recurrent wheezing in children: A randomized, double-blind, placebo-controlled clinical trial","volume":"204","author":"Nieto","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clim.2024.109930_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110184","article-title":"Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections","volume":"38","author":"Brandi","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2024.109930_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1066383","article-title":"Candida albicans V132 induces trained immunity and enhances the responses triggered by the polybacterial vaccine MV140 for genitourinary tract infections","volume":"13","author":"Mart\u00edn-Cruz","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0610","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-0716-0872-2_4","article-title":"CpG oligonucleotides as vaccine adjuvants","volume":"2197","author":"Kayraklioglu","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.clim.2024.109930_bb0615","article-title":"Th2 and Th17-associated immunopathology following SARS-CoV-2 breakthrough infection in spike-vaccinated ACE2-humanized mice","volume":"96","author":"Zhang","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.clim.2024.109930_bb0620","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4049\/jimmunol.162.4.2291","article-title":"Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria","volume":"162","author":"Elkins","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0625","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.4049\/jimmunol.173.8.5148","article-title":"CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection","volume":"173","author":"Deng","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0630","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.160.8.3627","article-title":"CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis","volume":"160","author":"Zimmermann","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0635","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/JVI.77.2.953-962.2003","article-title":"A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection","volume":"77","author":"Harandi","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2024.109930_bb0640","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.4049\/jimmunol.170.9.4717","article-title":"CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection","volume":"170","author":"Verthelyi","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0645","article-title":"CpG-DNA exerts antibacterial effects by protecting immune cells and producing bacteria-reactive antibodies","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2024.109930_bb0650","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41590-022-01388-8","article-title":"Inducing trained immunity in pro-metastatic macrophages to control tumor metastasis","volume":"24","author":"Ding","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003001","article-title":"Vaccines: from empirical development to rational design","volume":"8","author":"Rueckert","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2024.109930_bb0660","doi-asserted-by":"crossref","first-page":"eadl5685","DOI":"10.1126\/sciimmunol.adl5685","article-title":"\u201cTraining immunity\u201d against nosocomial pathogens","volume":"8","author":"Sch\u00e4fer","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0665","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic induction of trained immunity through the mevalonate pathway","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.109930_bb0670","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2018.09.003","article-title":"The Itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity","volume":"29","author":"Dom\u00ednguez-Andr\u00e9s","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.clim.2024.109930_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.02616-20","article-title":"Designing the next generation of vaccines: relevance for future pandemics","volume":"11","author":"Dom\u00ednguez-Andr\u00e9s","year":"2020","journal-title":"MBio"},{"issue":"20","key":"10.1016\/j.clim.2024.109930_bb0680","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41590-019-0399-9","article-title":"Adaptation and memory in immune responses","volume":"207","author":"Natoli","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0685","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1042\/BST20150214","article-title":"Regulation of PtdIns(3,4,5)P3\/Akt signalling by inositol polyphosphate 5-phosphatases","volume":"44","author":"Eramo","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.clim.2024.109930_bb0690","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.celrep.2018.09.092","article-title":"Targeting SHIP-1 in myeloid cells enhances trained immunity and boosts response to infection","volume":"25","author":"Saz-Leal","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2024.109930_bb0695","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1073\/pnas.0902636106","article-title":"Inositol phosphatase SHIP1 is a primary target of miR-155","volume":"106","author":"O\u2019Connell","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.109930_bb0700","doi-asserted-by":"crossref","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","article-title":"Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma","volume":"109","author":"Babar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.109930_bb0705","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cell.2020.09.059","article-title":"Trained immunity-promoting nanobiologic therapy suppresses tumor growth and potentiates checkpoint inhibition","volume":"183","author":"Priem","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.109930_bb0710","article-title":"Emerging nanoparticle platforms for CpG oligonucleotide delivery","author":"Li","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.clim.2024.109930_bb0715","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2018.09.008","article-title":"Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance","volume":"49","author":"Braza","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.109930_bb0720","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/ATVBAHA.114.303887","article-title":"Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes","volume":"34","author":"Bekkering","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2024.109930_bb0725","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.cell.2022.03.043","article-title":"Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities","volume":"185","author":"Li","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.109930_bb0730","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCRESAHA.117.312465","article-title":"Trained innate immunity as a novel mechanism linking infection and the development of atherosclerosis","volume":"122","author":"Leentjens","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.clim.2024.109930_bb0735","article-title":"Effect of BCG vaccination on proinflammatory responses in elderly individuals","volume":"7","author":"Kumar","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.clim.2024.109930_bb0740","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: randomized clinical trial of BCG vaccination against infection in the elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.109930_bb0745","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-specific effects of vaccines: current evidence and potential implications","volume":"39","author":"de Bree","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.05.014","article-title":"BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment","author":"Cirovic","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clim.2024.109930_bb0755","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: implication for vaccine design","author":"Covi\u00e1n","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.109930_bb0760","article-title":"Mucosal recombinant BCG vaccine induces lung-resident memory macrophages and enhances trained immunity via mTORC2\/HK1-mediated metabolic rewiring","volume":"105518","author":"Peng","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.109930_bb0765","first-page":"366","article-title":"MMR vaccination induces trained immunity via functional and metabolic reprogramming of \u03b3\u03b4 T cells","author":"R\u00f6ring","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.109930_bb0770","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.vaccine.2004.02.009","article-title":"Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau","volume":"22","author":"Aaby","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2024.109930_bb0775","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clinthera.2020.11.010","article-title":"Reduced mortality after oral polio vaccination and increased mortality after diphtheria-tetanus-pertussis vaccination in children in a low-income setting","volume":"43","author":"\u00d8land","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clim.2024.109930_bb0780","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.vaccine.2009.07.028","article-title":"TLR expression and NK cell activation after human yellow fever vaccination","volume":"27","author":"da Costa Neves","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2024.109930_bb0785","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.109930_bb0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009928","article-title":"Induction of trained immunity by influenza vaccination - impact on COVID-19","volume":"17","author":"Debisarun","year":"2021","journal-title":"PLoS Pathog."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162400041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162400041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:12:27Z","timestamp":1761495147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162400041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":158,"alternative-id":["S152166162400041X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.109930","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.109930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109930"}}